A patient from Zhaoqing was diagnosed with primary liver cancer 8 years ago. After receiving interventional therapy at Fuda Camcer Hospital, her condition was brought under control. However, due to a lack of timely follow-up, recurrence was found in the pelvic area. She then underwent cryoablation, and the tumor was again controlled, with the mass completely necrosed. There are no signs of recurrence, and her tumor marker AFP has dropped to 97. For liver cancer patients who are unwilling to undergo surgery, the combination of targeted therapy and immunotherapy can achieve the effect of prolonging the patient's survival.
